Arcellx (ACLX) Other Gross PP&E Adjustments (2021 - 2025)

Arcellx's quarterly Other Gross PP&E Adjustments came in at $23.4 million in Q4 2025, down 2.58% year-on-year from $24.0 million in Q4 2024, and up 200.64% quarter-over-quarter from -$23.2 million in Q3 2025.

Arcellx has reported Other Gross PP&E Adjustments for 5 years, with the latest figure at $23.4 million in Q4 2025.

  • For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 2.58% year-over-year to $23.4 million; the trailing twelve-month figure through Dec 2025 stood at $23.4 million (down 2.58% YoY), and the FY2025 full-year result was $23.4 million, down 2.58% from the prior year.
  • Other Gross PP&E Adjustments for Q4 2025 stood at $23.4 million, up from -$23.2 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $24.0 million in Q4 2024, with the low at -$29.6 million in Q1 2023.
  • Average Other Gross PP&E Adjustments over 5 years is -$13.8 million, with a median of -$23.6 million recorded in 2025.
  • Peak annual rise in Other Gross PP&E Adjustments reached 178.4% in 2023, while the deepest fall reached 826.41% in 2023.
  • Tracing ACLX's Other Gross PP&E Adjustments over 5 years: stood at $12.5 million in 2021, then sank by 266.42% to -$20.8 million in 2022, then soared by 178.4% to $16.3 million in 2023, then soared by 47.37% to $24.0 million in 2024, then retreated by 2.58% to $23.4 million in 2025.
  • The last three Other Gross PP&E Adjustments figures came in at $23.4 million (Q4 2025), -$23.2 million (Q3 2025), and -$23.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 23.37 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 23.37 Mn
Dec 31, 2025 23.37 Mn
Sep 30, 2025 -23.23 Mn
Sep 30, 2025 -23.23 Mn
Jun 30, 2025 -23.42 Mn
Jun 30, 2025 -23.42 Mn
Mar 31, 2025 -23.60 Mn
Mar 31, 2025 -23.60 Mn
Dec 31, 2024 23.99 Mn
Dec 31, 2024 23.99 Mn
Sep 30, 2024 -23.93 Mn
Sep 30, 2024 -23.93 Mn
Jun 30, 2024 -24.07 Mn
Jun 30, 2024 -24.07 Mn
Mar 31, 2024 -24.20 Mn
Mar 31, 2024 -24.20 Mn
Dec 31, 2023 16.28 Mn
Dec 31, 2023 16.28 Mn
Sep 30, 2023 -29.14 Mn
Sep 30, 2023 -29.14 Mn
Jun 30, 2023 -29.39 Mn
Jun 30, 2023 -29.39 Mn
Mar 31, 2023 -29.65 Mn
Mar 31, 2023 -29.65 Mn
Dec 31, 2022 -20.77 Mn
Dec 31, 2022 -20.77 Mn
Sep 30, 2022 -28.97 Mn
Sep 30, 2022 -28.97 Mn
Jun 30, 2022 -27.45 Mn
Jun 30, 2022 -27.45 Mn
Mar 31, 2022 -3.20 Mn
Mar 31, 2022 -3.20 Mn
Dec 31, 2021 12.48 Mn
Dec 31, 2021 12.48 Mn